{"DataElement":{"publicId":"5543290","version":"1","preferredName":"Pancreatic Neuroendocrine Tumor Present Histologic Grade Code","preferredDefinition":"A low or intermediate grade well differentiated tumor with neuroendocrine differentiation that arises from the pancreas_Being or existing in a specified place or at the specified time._Records the grade associated with a pancreatic cystic neuroendocrine tumor (NET).","longName":"5528848v1.0:5542901v1.0","context":"EDRN","contextVersion":"1","DataElementConcept":{"publicId":"5528848","version":"1","preferredName":"Pancreatic Neuroendocrine Tumor Present","preferredDefinition":"A low or intermediate grade well differentiated tumor with neuroendocrine differentiation that arises from the pancreas_Being or existing in a specified place or at the specified time.","longName":"5528371v1.0:2233878v1.0","context":"EDRN","contextVersion":"1","ObjectClass":{"publicId":"5528371","version":"1","preferredName":"Pancreatic Neuroendocrine Tumor","preferredDefinition":"A low or intermediate grade well differentiated tumor with neuroendocrine differentiation that arises from the pancreas","longName":"C27720","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Neuroendocrine Tumor","conceptCode":"C27720","definition":"A well differentiated, low, intermediate, or high grade neoplasm with neuroendocrine differentiation that arises from the pancreas.  According to the presence or absence of clinical syndromes that result from hormone hypersecretion, pancreatic neuroendocrine tumors are classified either as functional or nonfunctional.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3F4F7E4E-56D6-7FA1-E053-F662850AC326","latestVersionIndicator":"Yes","beginDate":"2016-10-20","endDate":null,"createdBy":"UMLLOADER_EDRN","dateCreated":"2016-10-20","modifiedBy":"ONEDATA","dateModified":"2016-10-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2233878","version":"1","preferredName":"Present","preferredDefinition":"Being or existing in a specified place or at the specified time.","longName":"C25626","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Present","conceptCode":"C25626","definition":"Being or existing in a specified place or at the specified time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F970CDF6-F829-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"ONEDATA","dateModified":"2005-06-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3F5003A8-AE62-0AAF-E053-F662850A0FFC","latestVersionIndicator":"Yes","beginDate":"2016-10-20","endDate":null,"createdBy":"UMLLOADER_EDRN","dateCreated":"2016-10-20","modifiedBy":"ALEYR","dateModified":"2017-09-22","changeDescription":"2/28/17 changed context from Test to EDRN. jk 2017-09-22: Changed the conceptual domain from UML Model to Diagnosis and released the DEC.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5542901","version":"1","preferredName":"Pancreatic Neuroendocrine Tumor Histologic Grade Code","preferredDefinition":"Records the grade associated with a pancreatic cystic neuroendocrine tumor (NET).","longName":"5542901v1.0","context":"EDRN","contextVersion":"1","type":"Enumerated","dataType":"NUMBER","minLength":null,"maxLength":"2","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"99","valueDescription":"Unknown","ValueMeaning":{"publicId":"2565695","version":"1","preferredName":"Unknown","longName":"2565695","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CDAC-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-02-26","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-02-26","modifiedBy":"MMADDINENI","dateModified":"2024-02-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"45D83C77-D3A0-0724-E053-F662850A4965","beginDate":"2017-01-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-01-11","modifiedBy":"ONEDATA","dateModified":"2017-01-11","deletedIndicator":"No"},{"value":"3","valueDescription":"Grade 3","ValueMeaning":{"publicId":"5622671","version":"1","preferredName":"Grade 3","longName":"5622671","preferredDefinition":"A morphologic qualifier indicating that a cancerous lesion is poorly differentiated.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Grade 3","conceptCode":"C28079","definition":"A morphologic qualifier indicating that a cancerous lesion is poorly differentiated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"45D39BCC-34D0-6918-E053-F662850A008A","latestVersionIndicator":"Yes","beginDate":"2017-01-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-01-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"45D83C77-D3AA-0724-E053-F662850A4965","beginDate":"2017-01-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-01-11","modifiedBy":"ONEDATA","dateModified":"2017-01-11","deletedIndicator":"No"},{"value":"2","valueDescription":"Grade 2","ValueMeaning":{"publicId":"5622672","version":"1","preferredName":"Grade 2","longName":"5622672","preferredDefinition":"A morphologic qualifier indicating that a cancerous lesion is moderately differentiated.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Grade 2","conceptCode":"C28078","definition":"A morphologic qualifier indicating that a cancerous lesion is moderately differentiated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"45D39BCC-34F2-6918-E053-F662850A008A","latestVersionIndicator":"Yes","beginDate":"2017-01-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-01-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"45D83C77-D3B4-0724-E053-F662850A4965","beginDate":"2017-01-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-01-11","modifiedBy":"ONEDATA","dateModified":"2017-01-11","deletedIndicator":"No"},{"value":"1","valueDescription":"Grade 1","ValueMeaning":{"publicId":"3270009","version":"1","preferredName":"Grade 1","longName":"3270009","preferredDefinition":"A morphologic qualifier indicating that a cancerous lesion is well differentiated.\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Grade 1","conceptCode":"C28077","definition":"A morphologic qualifier indicating that a cancerous lesion is well differentiated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AC4B0802-7E3A-C755-E040-BB89AD43108E","latestVersionIndicator":"Yes","beginDate":"2011-09-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"45D83C77-D3BE-0724-E053-F662850A4965","beginDate":"2017-01-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-01-11","modifiedBy":"ONEDATA","dateModified":"2017-01-11","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"5624452","version":"1","preferredName":"Pancreatic Neuroendocrine Tumor Histologic Grade Code","preferredDefinition":"A low or intermediate grade well differentiated tumor with neuroendocrine differentiation that arises from the pancreas.  According to the presence or absence of clinical syndromes that result from hormone hypersecretion, pancreatic neuroendocrine tumors are classified either as functional or nonfunctional.:The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior of the particular tumor. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease. Certain types of cancers, such as soft tissue sarcoma, primary brain tumors, lymphomas, and breast have special grading systems.:A symbol or combination of symbols which is assigned to the members of a collection.","longName":"C27720:C18000:C25162","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Neuroendocrine Tumor","conceptCode":"C27720","definition":"A well differentiated, low, intermediate, or high grade neoplasm with neuroendocrine differentiation that arises from the pancreas.  According to the presence or absence of clinical syndromes that result from hormone hypersecretion, pancreatic neuroendocrine tumors are classified either as functional or nonfunctional.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Histologic Grade","conceptCode":"C18000","definition":"The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior of the particular tumor. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease. Certain types of cancers, such as soft tissue sarcoma, primary brain tumors, lymphomas, and breast have special grading systems.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"45D83C77-D389-0724-E053-F662850A4965","latestVersionIndicator":"Yes","beginDate":"2017-01-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-01-11","modifiedBy":"ONEDATA","dateModified":"2017-01-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3FB53D79-BC18-616C-E053-F662850AEC9A","latestVersionIndicator":"Yes","beginDate":"2016-10-25","endDate":null,"createdBy":"UMLLOADER_EDRN","dateCreated":"2016-10-25","modifiedBy":"ALEYR","dateModified":"2017-09-22","changeDescription":"2017-09-22 RR: Added a max length of 2 and released the VD.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5542681","version":"1","longName":"EDRN_CDE_Project","context":"EDRN","ClassificationSchemeItems":[{"publicId":"10000601","version":"1","longName":"EDRN-CDEs","context":"EDRN"},{"publicId":"5542682","version":"1","longName":"Biospecimen CDEs","context":"EDRN"}]},{"publicId":"5806857","version":"1","longName":"HCMI (Human Cancer Models Initiative)","context":"OCG","ClassificationSchemeItems":[{"publicId":"5777527","version":"1","longName":"Pancreatic","context":"OCG"}]}],"AlternateNames":[{"name":"Pancreatic_Neuroendocrine_Tumor:SPECIMEN_PANCREAS_NETGRADE_CODE_3314","type":"UML Class:UML Attr","context":"EDRN"},{"name":"EDRN-CDEs.Pancreatic_Neuroendocrine_Tumor.SPECIMEN_PANCREAS_NETGRADE_CODE_3314","type":"UML Qualified Attr","context":"EDRN"},{"name":"OCG","type":"USED_BY","context":"OCG"},{"name":"pancreatic_neuroendocrine_tumor_grade","type":"HCMI Name","context":"OCG"},{"name":"Alliance","type":"USED_BY","context":"Alliance"}],"ReferenceDocuments":[{"name":"Grading for cystic neuroendoc","type":"Preferred Question Text","description":"Grading for cystic neuroendocrine tumor:","url":null,"context":"EDRN"},{"name":"CRF Text1","type":"Alternate Question Text","description":"Tumor Grade","url":null,"context":"Alliance"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3FB565A9-625B-2F6F-E053-F662850AEE9B","latestVersionIndicator":"Yes","beginDate":"2016-10-25","endDate":null,"createdBy":"UMLLOADER_EDRN","dateCreated":"2016-10-25","modifiedBy":"MORENOC","dateModified":"2021-12-06","changeDescription":"3/4/17 added Pref Question, updated long name. jk 2017-09-22 RR: Released the CDE.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}